Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-026986

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Braslyn Ltd.
10% Owner
Period of report
Nov 16, 2017
Accepted (ET)
Nov 20, 2017 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 16, 2017P144,736$13.00A1,372,510D
Common StockF2Nov 16, 2017P255,264$13.00A3,135,966D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to purchase)F1,F3$0.001Nov 16, 2017P801,448ANov 16, 2017—Common Stock801,448801,448D
Warrant (right to purchase)F2,F3$0.001Nov 16, 2017P1,413,475ANov 16, 2017—Common Stock1,413,4751,413,475D

Explanation of responses